Concluded that the development and progression of acute leukemia are closely related to the expression levels of ILP-2, and that high expression of ILP-2 may increase the insensitivity of leukemia to chemotherapeutic drugs, thereby reducing the therapeutic effect of the drugs. Here, BIRC8 is linked to leukemia.